Conjunctival Staining
Showing 26 - 50 of 1,110
Diabetic Eye Problems Trial in Shenyang (3% Diquafosol tetrasodium)
Not yet recruiting
- Diabetic Eye Problems
- 3% Diquafosol tetrasodium
-
Shenyang, Liaoning, ChinaHe Eye Hospital
Feb 14, 2022
Dry Eye Syndromes Trial in Kowloon, Shatin (TCM ultrasonic atomization treatment with herbal Compound Decoction (CD), TCM
Not yet recruiting
- Dry Eye Syndromes
- TCM ultrasonic atomization treatment with herbal Compound Decoction (CD)
- +4 more
-
Kowloon, Hong Kong
- +3 more
Oct 13, 2023
Recurrent Pterygium, Micro-Conjunctival Autografting Combined With Amniotic Membrane Transplantation Trial in Nanchang
Completed
- Recurrent Pterygium
- Micro-Conjunctival Autografting Combined With Amniotic Membrane Transplantation
- Micro-Conjunctival Autograft Combined with Amniotic Membrane Transplantation
- Conventional Autologous Conjunctival Transplantation
-
Nanchang, Jiangxi, Chinathe Second Affiliated Hospital of Nanchang University
May 3, 2022
Keratoconjunctivitis Sicca, Dry Eye Disease Trial in Cleveland (OTX-101 0.05%, OTX-101 0.09%, Vehicle)
Completed
- Keratoconjunctivitis Sicca
- Dry Eye Disease
- OTX-101 0.05%
- +2 more
-
Cleveland, Ohio(unnamed)
Aug 26, 2022
Contact Lens Complication Trial in Valladolid (Aquoral Lipo (Esteve), Hyabak (Thea))
Recruiting
- Contact Lens Complication
- Aquoral Lipo (Esteve)
- Hyabak (Thea)
-
Valladolid, SpainIOBA - University of Valladolid
Nov 28, 2022
Dry Eye Trial in Guangzhou (Cyclosporine, oculus keratograph, in vivo laser confocal microscopy, Functional slit lamp
Recruiting
- Dry Eye
- Cyclosporine
- oculus keratograph, in vivo laser confocal microscopy, Functional slit lamp biomicroscopy
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center, Sun Yat-sen University
Feb 9, 2022
Dry Eye Syndromes Trial in France, Spain (Eyestil Plus®)
Completed
- Dry Eye Syndromes
- Eyestil Plus®
-
Bordeaux, France
- +11 more
Dec 22, 2022
Immune Cell Signatures in Autoimmunity and Dry Eye Syndrome
Recruiting
- Autoimmunity
- Dry Eye Syndrome
- Cross-sectional study
-
Singapore, SingaporeCynthia Boo
Mar 22, 2022
Dry Eye Syndromes Trial in Korea, Republic of (SCAI-001 0.01% eyedrop, SCAI-001 0.02% eyedrop, Restasis 0.05% eyedrop)
Recruiting
- Dry Eye Syndromes
- SCAI-001 0.01% eyedrop
- +2 more
-
Bucheon, Korea, Republic of
- +10 more
Feb 21, 2023
Dry Eye Disease Trial in Bellaire (Topical spironolactone ophthalmic solution, 0.005 mg/cc, Placebo)
Not yet recruiting
- Dry Eye Disease
- Topical spironolactone ophthalmic solution, 0.005 mg/cc
- Placebo
-
Bellaire, TexasRichard W Yee, MD PLLC
Aug 16, 2023
Dry Eye, Dry Eye Syndromes Trial in Lutz, Tampa (Nutritears®, Placebo)
Recruiting
- Dry Eye
- Dry Eye Syndromes
- Nutritears®
- Placebo
-
Lutz, Florida
- +2 more
Jul 28, 2022
Dry Eye Syndrome Trial in Seoul (SA001 Low dose, SA001 Mid dose, SA001 High dose)
Completed
- Dry Eye Syndrome
- SA001 Low dose
- +3 more
-
Seoul, Korea, Republic ofSeoul St. Mary's Hospital
Mar 4, 2022
Astigmatism Trial in Manchester (Soft Toric Custom Made Contact lens, Soft Spherical Contact Lenses, Spectacle Correction)
Active, not recruiting
- Astigmatism
- Soft Toric Custom Made Contact lens
- +2 more
-
Manchester, United KingdomEurolens Research
May 4, 2022
Dry Eye, Dry Eye Syndromes Trial in United States (Vehicle Opthalmic Solution, PL9643 Opthalmic Solution)
Recruiting
- Dry Eye
- Dry Eye Syndromes
- Vehicle Opthalmic Solution
- PL9643 Opthalmic Solution
-
Newport Beach, California
- +9 more
Jan 20, 2022
Dry Eye Disease Trial in Hanzhou (Pluripotent Stem Cell-derived Mesenchymal Stem Cell Exosome (PSC-MSC-Exo) Eye Drops)
Not yet recruiting
- Dry Eye Disease
- Pluripotent Stem Cell-derived Mesenchymal Stem Cell Exosome (PSC-MSC-Exo) Eye Drops
-
Hanzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Feb 21, 2023
Dry Eye Syndromes Trial in France, Poland, Spain (Cationorm Pro, Vismed)
Recruiting
- Dry Eye Syndromes
- Cationorm Pro
- Vismed
-
La Rochefoucauld, France
- +9 more
May 16, 2022
Dry Eye Syndromes Trial in France (Alocross 0.2% Unit Dose, Vismed)
Recruiting
- Dry Eye Syndromes
- Alocross 0.2% Unit Dose
- Vismed
-
Bordeaux, France
- +9 more
May 16, 2022
Dry Eye Trial in Xiamen (HBM9036 0.25% Ophthalmic Solution, Placebo)
Recruiting
- Dry Eye
- HBM9036 0.25% Ophthalmic Solution
- Placebo
-
Xiamen, Fujian, ChinaXiamen Eye Center of Xiamen University
Jun 16, 2022
Dry Eye, Contact Lens Complication Trial in Birmingham (HydroEye®)
Not yet recruiting
- Dry Eye
- Contact Lens Complication
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Aug 19, 2022
Keratoconjunctivitis Sicca Trial in Rancho Cordova, Edgewood, New York (cyclosporine, vehicle of OTX-101)
Completed
- Keratoconjunctivitis Sicca
- cyclosporine
- vehicle of OTX-101
-
Rancho Cordova, California
- +2 more
Nov 18, 2021
Dry Eye Disease Trial in United States (CequaTM (Cyclosporine 0.09%) ophthalmic solution)
Completed
- Dry Eye Disease
- CequaTM (Cyclosporine 0.09%) ophthalmic solution
-
Fort Myers, Florida
- +4 more
Sep 8, 2022
Dry Eye Disease Trial in Shenyang (Orthokeratology, Spectacles)
Not yet recruiting
- Dry Eye Disease
- Orthokeratology
- Spectacles
-
Shenyang, Liaoning, ChinaHe Eye Hospital
Aug 29, 2023
Dry Eye Syndromes Trial in Seoul (SJP002 BID, SJP002 QID, SJP002 Placebo 1)
Completed
- Dry Eye Syndromes
- SJP002 BID
- +3 more
-
Seoul, Korea, Republic ofSeoul St. Mary's Hospital
Mar 30, 2022